Reflecting on Our Journey

As I take a moment to pen this piece, a profound sense of accomplishment washes over me. It’s remarkable to think I am on the brink of my 100th podcast episode. At the beginning of this journey, I aspired to reach this milestone, yet I could never have foreseen the significant influence it would have on both my audience and myself.

The pandemic brought forth an unprecedented array of challenges for both businesses and individuals, prompting me to explore ways to keep my community engaged and connected. This exploration led me to the enlightening world of podcasting and newsletters, which emerged as powerful tools for fostering connection and alleviating feelings of isolation.

Throughout the past few years, I have navigated a landscape of learning, missteps, experimentation, and continual evolution of my show. I extend my heartfelt gratitude to every guest who has participated in this journey and to those who have generously contributed through donations and sponsorships, allowing me to enhance the production quality of the podcast.

A special acknowledgment goes to my listeners, whose clicks, downloads, comments, and shares have been invaluable. The success of any show hinges on its audience, and I am incredibly thankful to have cultivated something that serves you, the listener. Current statistics reveal that the podcast reaches over 9,000 listeners worldwide, with a significant portion located in Europe, 40% in North America, and 10% from other regions.

Moreover, I am thrilled to announce that partnerships with Podcastnotes.org and Labiotech.eu have expanded the podcast’s reach to over 70,000 thought leaders globally. As I strive to refine and enhance my show, I wish to express my appreciation for your support. Your engagement is critical for widening the audience, enabling more individuals to reap the benefits of the content.

I remain dedicated to advocating for scientific entrepreneurs and contributing to a brighter future for humanity, provided I have the necessary funding and that my listeners affirm the relevance of the show. To commemorate this milestone, I have curated a special episode, presenting the five most downloaded episodes from the past three years.

Top 5 Most Downloaded Episodes

Number 5: Sascha Bucher — Forty51 Ventures — Episode #34 — February 11, 2021

Are you an entrepreneur seeking guidance in the intricate world of investments? In this episode, I converse with Sascha Bucher, a venture capital specialist with extensive experience in deal structuring within the pharmaceutical sector. Having worked with leading firms like Roivant Sciences, Roche, and UBS, Sascha has facilitated transactions worth billions. He and his team at Forty51 Ventures aim to bridge the "Life Science Valley of Death" in Central Europe, providing essential resources for life science entrepreneurs.

However, success in drug development is no walk in the park; it demands rigorous research and the ability to translate scientific discoveries into viable products. In this discussion, Sascha shares insider tips on fostering relationships with business development, research and development, and executive-level stakeholders in the industry.

Number 4: Ana Trbovich — Episode #37 — March 7, 2021

Join us for an enlightening conversation about the transformative potential of blockchain technology in the energy sector with Ana Trbovich, co-founder and COO of Grid Singularity. With her extensive background in innovation and entrepreneurship, particularly in Berlin's tech scene, Ana sheds light on how blockchain is reshaping the energy landscape beyond mere payment systems.

Her expertise extends to her roles on various advisory boards, including the UNECE Carbon Neutrality and DENA SET Hub. Ana’s impressive credentials also include a professorship in Entrepreneurship at FEFA, one of Belgrade's top business schools.

Number 3: Jonathan Sporn — Episode 79 — June 28, 2022

As the global mental health crisis continues to affect millions, Dr. Jonathan Sporn, CEO of Gilgamesh Pharmaceutical, discusses the urgent need for innovative solutions in mental health care. This episode offers insights into the promising advancements in psychedelic drug development and their potential impact on mental health treatment.

Number 2: Heike Schön — Episode 71 — March 28, 2022

In this episode, Heike Schön, Managing Director of Lumis International, shares her expertise on navigating the complexities of clinical trials, shedding light on common pitfalls and strategies for success.

Number 1: Alexander Belcredi — Episode 9 — April 1, 2020

To wrap up our countdown, we revisit my conversation with Alexander Belcredi, co-founder of Phagomed, whose approach to addressing bacterial infections without antibiotics has garnered significant attention. He shares insights into the challenges of drug development and the importance of strategic fundraising.

Looking Ahead: The Future of the Podcast

As I gaze toward 2023, I have set ambitious objectives to expand the podcast’s reach and impact. One of my primary goals is to transition the podcast into a video format, enhancing the platform for showcasing our speakers' insights and brands.

To realize this vision, I am on the lookout for speakers who can share knowledge in various fields, including holistic health, preventive medicine, pharma and health tech, artificial intelligence, climate change, and entrepreneurship.

Other goals for 2023 include increasing organic reach on social media, forging additional media partnerships, and enhancing cash flow to support promotional efforts for partner brands. I aim to produce 50 more episodes featuring inspiring speakers to amplify their messages.

Overall, I am filled with optimism for the opportunities and challenges that lie ahead in 2023, and I remain committed to making a positive impact within our community.